2
Total investments
0
Early stage
2
Mid stage
0
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
2019
Madorra is empowering women to live fuller, richer, healthier lives. Our first product is changing the paradigm for treating vaginal dryness by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. We’re giving postmenopausal women and breast cancer survivors the power to choose the non-hormonal treatment option they want. Madorra has developed the first, non-invasive, non-hormonal medical device to treat vaginal atrophy. This is an easy-to-use, at-home device, providing both immediate and long-term benefits.
Investor
2018
Raydiant Oximetry, Inc... A company dedicated to the mission of keeping mothers and babies safe during childbirth. It is hard to imagine a greater honor and privilege than working towards this goal. We are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. This will help obstetricians and patients have more and better information that they need to ensure that it is safe to continue labor or confidently decide that a cesarean section is needed. It is our hope that we will improve maternal and fetal outcomes, decrease cesarean delivery rates, and thus overall decrease healthcare costs worldwide by doing so.
Experience · 2 entries
All (2)
Investments (2)
2019
Investor
2019
Madorra is empowering women to live fuller, richer, healthier lives. Our first product is changing the paradigm for treating vaginal dryness by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. We’re giving postmenopausal women and breast cancer survivors the power to choose the non-hormonal treatment option they want. Madorra has developed the first, non-invasive, non-hormonal medical device to treat vaginal atrophy. This is an easy-to-use, at-home device, providing both immediate and long-term benefits.
2018
Investor
2018
Raydiant Oximetry, Inc... A company dedicated to the mission of keeping mothers and babies safe during childbirth. It is hard to imagine a greater honor and privilege than working towards this goal. We are developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. This will help obstetricians and patients have more and better information that they need to ensure that it is safe to continue labor or confidently decide that a cesarean section is needed. It is our hope that we will improve maternal and fetal outcomes, decrease cesarean delivery rates, and thus overall decrease healthcare costs worldwide by doing so.